首页> BJU international> Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.

Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mattia,Longoni

第一单位： Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.;Vita-Salute San Raffaele University, Milan, Italy.

作者： Mattia,Longoni ^[1] ; Pietro,Scilipoti ^[1] ; Chiara,Re ^[1] ; Giuseppe,Rosiello ^[1] ; Luigi,Nocera ^[1] ; Francesco,Pellegrino ^[1] ; Giuseppe,Basile ^[1] ; Mario,de Angelis ^[1] ; Leonardo,Quarta ^[1] ; Giusy,Burgio ^[1] ; Andrea,Necchi ^[2] ; Antonio,Cigliola ^[2] ; Arturo,Chiti ^[3] ; Maria,Picchio ^[3] ; Andrea,Salonia ^[1] ; Alberto,Briganti ^[1] ; Francesco,Montorsi ^[1] ; Marco,Moschini ^[1]

作者单位： Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.;Vita-Salute San Raffaele University, Milan, Italy. ^[1] Department of Genitourinary Medical Oncology, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy. ^[2] Department of Nuclear Medicine, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy. ^[3]

关键词 18F‐FDG PET/CT bladder cancer lymph node neoadjuvant therapy pelvic lymph node dissection radical cystectomy staging